← All organizations

Alba Therapeutics

For profitContributed to NMEWebsite ↗

Also known as: Alba Therapeutics Corp | Alba Therapeutics Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Oct 1, 2011

Acquired by Cephalon → Teva on Feb 17, 2011

Timeline

2000s

Jan 1, 2004
Alba Therapeutics— Founded

2010s

Feb 17, 2011
Cephalon— Acquired By
Oct 14, 2011
Teva— Now

Drugs by trial phase (2 distinct, 7 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Celiac Disease

Recent trials (12)

NCT01396213Lead sponsorPhase 2Oct 1, 2011
NCT00889473Lead sponsorPhase 2Apr 1, 2009
NCT00889473Study directorPhase 2Apr 1, 2009
NCT00620451Study directorPhase 2Feb 1, 2008
NCT00620451Lead sponsorPhase 2Feb 1, 2008
NCT00492960Study directorPhase 2Aug 1, 2007
NCT00492960Lead sponsorPhase 2Aug 1, 2007
NCT00362856Lead sponsorPhase 2Aug 1, 2006
NCT00386490Study chairPhase 1Jan 1, 2006
NCT00386490Lead sponsorPhase 1Jan 1, 2006
NCT00386165Lead sponsorPhase 1Jan 1, 2006
NCT00386165Study chairPhase 1Jan 1, 2006

Details

Founded: Baltimore, MD, US Jan 1, 2004
Last known activity: Oct 1, 2011